Repurposing drugs during the COVID-19 pandemic and beyond.
作者信息
Ravi Srividya, Jadhav Sammita, Vaidya Anuradha, Ghooi Ravindra
机构信息
Symbiosis School of Biological Sciences (SSBS) (formerly Symbiosis School of Biomedical Sciences), Symbiosis International (Deemed University), Gram-Lavale, Taluka-Mulshi Dist, Pune 412115, India.
Symbiosis Institute of Health Sciences, Symbiosis International (Deemed University), Gram-Lavale, Taluka-Mulshi Dist, Pune 412115, India.
出版信息
Pharm Pat Anal. 2021 Jan;10(1):9-12. doi: 10.4155/ppa-2020-0031. Epub 2021 Jan 15.
Abstract
摘要
相似文献
1
Repurposing drugs during the COVID-19 pandemic and beyond.在新冠疫情期间及之后对药物进行重新利用。
Pharm Pat Anal. 2021 Jan;10(1):9-12. doi: 10.4155/ppa-2020-0031. Epub 2021 Jan 15.
2
Artificial intelligence in COVID-19 drug repurposing.人工智能在新冠病毒药物再利用中的应用。
Lancet Digit Health. 2020 Dec;2(12):e667-e676. doi: 10.1016/S2589-7500(20)30192-8. Epub 2020 Sep 18.
3
Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to.新冠病毒治疗学：从计算到实践——我们现在在哪里，我们的前进方向在哪里。
Mol Divers. 2021 Feb;25(1):625-659. doi: 10.1007/s11030-020-10134-x. Epub 2020 Sep 2.
4
Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.重新定位药物以应对 COVID-19 大流行——一个洞察。
Curr Pharm Biotechnol. 2021;22(2):192-199. doi: 10.2174/1389201021999200820155927.
5
Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.小分子药物治疗 COVID-19 的发现：临床研究综述。
Mini Rev Med Chem. 2021;21(12):1431-1456. doi: 10.2174/1389557521666201228145755.
6
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV.抗 SARS-CoV-1、SARS-CoV-2 和 MERS-CoV 的药物再利用。
Future Microbiol. 2021 Nov;16:1341-1370. doi: 10.2217/fmb-2021-0019. Epub 2021 Nov 10.
7
Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.药物重定位的药物发现：在 21 世纪抗击 COVID-19。
Mini Rev Med Chem. 2021;21(1):3-9. doi: 10.2174/1389557520999200824103803.
8
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.靶向 SARS-CoV-2 主蛋白酶：一项计算药物再利用研究。
Arch Med Res. 2021 Jan;52(1):38-47. doi: 10.1016/j.arcmed.2020.09.013. Epub 2020 Sep 17.
9
Drug repositioning is an alternative for the treatment of coronavirus COVID-19.药物重定位是治疗冠状病毒 COVID-19 的一种替代方法。
Int J Antimicrob Agents. 2020 Jun;55(6):105969. doi: 10.1016/j.ijantimicag.2020.105969. Epub 2020 Apr 9.
10
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M Protease.利用定量构效关系、对接和分子动力学对严重急性呼吸综合征冠状病毒2 M蛋白酶的潜在抑制剂进行药物再利用研究
Molecules. 2020 Nov 6;25(21):5172. doi: 10.3390/molecules25215172.
本文引用的文献
1
Primed for global coronavirus pandemic: Emerging research and clinical outcome.为全球冠状病毒大流行做好准备：新兴研究与临床结果。
Eur J Med Chem. 2021 Jan 1;209:112862. doi: 10.1016/j.ejmech.2020.112862. Epub 2020 Sep 19.
2
Favipiravir: A new and emerging antiviral option in COVID-19.法匹拉韦：COVID-19 中一种新兴的抗病毒新选择。
Med J Armed Forces India. 2020 Oct;76(4):370-376. doi: 10.1016/j.mjafi.2020.08.004. Epub 2020 Sep 2.
3
Tackling SARS-CoV-2: proposed targets and repurposed drugs.应对 SARS-CoV-2：拟议的靶标和已上市药物。
Future Med Chem. 2020 Sep;12(17):1579-1601. doi: 10.4155/fmc-2020-0147. Epub 2020 Jun 22.
4
The current understanding and potential therapeutic options to combat COVID-19.当前对抗 COVID-19 的理解和潜在治疗选择。
Life Sci. 2020 Aug 1;254:117765. doi: 10.1016/j.lfs.2020.117765. Epub 2020 May 8.
5
Challenges and opportunities of drug repositioning.药物重定位的挑战与机遇。
Trends Pharmacol Sci. 2013 May;34(5):267-72. doi: 10.1016/j.tips.2013.03.004. Epub 2013 Apr 12.
6
Old friends in new guise: repositioning of known drugs with structural bioinformatics.旧友新颜：结构生物信息学定位已知药物。
Brief Bioinform. 2011 Jul;12(4):312-26. doi: 10.1093/bib/bbr011. Epub 2011 Mar 26.
7
The Indian Medical Council (professional conduct, etiquette and ethics) regulations, 2002.《2002年印度医学理事会（专业行为、礼仪与道德）条例》
Issues Med Ethics. 2002 Jul-Sep;10(3):66-70.
Zotero 插件